Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
No shortage on file

OMNIPAQUE 350

GE HEALTHCARE CANADA INC

Quick answers

Is there a shortage of OMNIPAQUE 350 in Canada?

No. There is no current shortage of OMNIPAQUE 350 755MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on file5 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

OMNIPAQUE 300

GE HEALTHCARE CANADA INC

647MG · DIN 02172747

Different strengthSame dosage formDifferent routeNo current shortage

OMNIPAQUE 300 LIQ IV SAR 647MG/ML

SANOFI CANADA, INC.

300MG · DIN 02018128

Different strengthDifferent dosage formDifferent routeNo current shortage

OMNIPAQUE 240 LIQ IV SAR 518MG/ML

SANOFI CANADA, INC.

240MG · DIN 02018101

Different strengthDifferent dosage formDifferent routeNo current shortage

OMNIPAQUE 180 LIQ SAR 388MG/ML

SANOFI CANADA, INC.

180MG · DIN 02018098

Different strengthDifferent dosage formDifferent routeNo current shortage

OMNIPAQUE 350 LIQ IV 755MG/ML

SANOFI CANADA, INC.

350MG · DIN 02018136

Different strengthDifferent dosage formDifferent routeNo current shortage

DIN

02172755

Strength

755MG

Dosage Form

SOLUTION

Route

ORAL INTRAVASCULAR

Active Ingredient

IOHEXOL

See all IOHEXOL products →

Shortage History

Other Products from GE HEALTHCARE CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.